Empowered Patient Podcast

Ronen Eckhouse, Co-Founder and CEO of Rapid Medical, identifies the limitations of current stroke treatments, which are primarily effective for large vessel occlusions.  The Rapid Medical TIGERTRIEVER device is designed to safely and effectively treat strokes and remove clots in smaller vessels deeper in the brain.  The unique adjustability of the device allows physicians to control the size and force during a procedure, allowing for precise and safer clot removal in complex anatomies. Ronen explains, "So the quicker or the less time there is between the stroke and the ability to open the occlusions and resupply the brain with oxygen, the better. There are two types of treatments. One is a drug called TPA. It's a clot buster, and that can be administered up to four and a half hours. And then there's what's called thrombectomy, which is basically using a catheter to get to the clot and then removing the clot with a catheter or stent, kind of in mechanical terms. But today, that's only applicable to what's for